However, Medicrea, a company focused on orthopedic spine implants, reported an 8.5 percent sales increase in the United States. The company plans to develop sales activity in the U.S. with its PASS LP product and obtain FDA approval for its K-Jaws technology in 2013.
The group has also been in negotiation with potential American partners for its Granvia-C cervical disc.
More Articles on Spine Devices:
K2M Launches VENADO Biologic Bone Graft System
Amedica Valeo Interbody Fusion Device Hits 10k Implantations
X-spine Receives FDA Clearance for Silex Sacroiliac Joint Fusion Device
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
